# Multimodal Therapy Impact on Pancreatic Cancer Survival

> **NCT06938906** · — · ACTIVE_NOT_RECRUITING · sponsor: **National Cheng Kung University** · enrollment: 405 (actual)

## Conditions studied

- Pancreatic Cancer
- Neoadjuvant Chemotherapy
- Pancreatectomy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06938906
- **Lead sponsor:** National Cheng Kung University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2011-01-03
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 405 (ACTUAL)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06938906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06938906, "Multimodal Therapy Impact on Pancreatic Cancer Survival". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06938906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*